AIM IMMUNOTECH INC. Lease, Cost
AIM IMMUNOTECH INC. (AIM) reported Lease, Cost of $237.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-07
- AIM IMMUNOTECH INC. lease, cost for the quarter ending 2026-06-30 was $100.00K, a 37.89% decline year-over-year.
- AIM IMMUNOTECH INC. lease, cost for the quarter ending 2026-03-31 was $137.00K, a 13.29% decline year-over-year.
- AIM IMMUNOTECH INC. lease, cost for the quarter ending 2025-12-31 was $103.00K, a 33.97% decline year-over-year.
- AIM IMMUNOTECH INC. lease, cost for the quarter ending 2025-09-30 was $122.00K, a 22.29% decline year-over-year.
- AIM IMMUNOTECH INC. lease, cost for fiscal 2025 was $544.00K, a 7.33% decline from fiscal 2024.
- AIM IMMUNOTECH INC. lease, cost for fiscal 2024 was $587.00K, a 5.78% decline from fiscal 2023.
- AIM IMMUNOTECH INC. lease, cost for fiscal 2023 was $623.00K, a 183675.81% increase from fiscal 2022.
- AIM IMMUNOTECH INC. lease, cost for fiscal 2022 was $339.00.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $237.00K 10-Q · filed 2026-08-07 | $340.00K derived: sum of 3 quarters · filed 2026-08-07 | $462.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $137.00K 10-Q · filed 2026-05-15 | $240.00K derived: sum of 2 quarters · filed 2026-05-15 | $362.00K derived: sum of 3 quarters · filed 2026-05-15 | $523.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $225.00K derived: sum of 2 quarters · filed 2026-03-27 | $386.00K derived: sum of 3 quarters · filed 2026-08-07 | $544.00K 10-K · filed 2026-03-27 | |
| 2025-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $283.00K derived: sum of 2 quarters · filed 2026-08-07 | $441.00K 10-Q · filed 2025-11-17 | $597.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $319.00K 10-Q · filed 2026-08-07 | $475.00K derived: sum of 3 quarters · filed 2026-08-07 | $632.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $158.00K 10-Q · filed 2026-05-15 | $314.00K derived: sum of 2 quarters · filed 2026-05-15 | $471.00K derived: sum of 3 quarters · filed 2026-05-15 | $622.00K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $313.00K derived: sum of 2 quarters · filed 2026-03-27 | $464.00K derived: sum of 3 quarters · filed 2026-03-27 | $587.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $308.00K derived: sum of 2 quarters · filed 2025-11-17 | $431.00K 10-Q · filed 2025-11-17 | $587.00K derived: sum of 4 quarters · filed 2025-11-17 | |
| 2024-06-30 | $151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $274.00K 10-Q · filed 2025-08-14 | $430.00K derived: sum of 3 quarters · filed 2025-08-14 | $555.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $123.00K 10-Q · filed 2025-05-15 | $279.00K derived: sum of 2 quarters · filed 2025-05-15 | $404.00K derived: sum of 3 quarters · filed 2025-05-15 | $659.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $281.00K derived: sum of 2 quarters · filed 2025-03-27 | $536.00K derived: sum of 3 quarters · filed 2025-03-27 | $623.00K 10-K · filed 2025-03-27 | $623.00 10-K · filed 2024-04-01 |
| 2023-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $380.00K derived: sum of 2 quarters · filed 2024-11-14 | $467.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $255.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $342.00K 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $87.00K 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | $339.00 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |